HYPERGLYCAEMIC CRISIS

HYPERGLYCAEMIC CRISIS was reported 52 times

HYPERGLYCAEMIC CRISIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 GLP-2 Analog [EPC] 4 0.0003
1 Somatostatin Analog [EPC] 2 0.0003
2 Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] 1 0.0002
3 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
4 Glycopeptide Antibacterial [EPC] 9 0.0001
5 PCSK9 Inhibitor [EPC] 2 0.0001
6 Dipeptidyl Peptidase 4 Inhibitor [EPC] 2 0.0001
7 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 6 0.0001
8 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
9 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
10 Aromatase Inhibitor [EPC] 4 0.0000
11 Proteasome Inhibitor [EPC] 4 0.0000
12 Insulin Analog [EPC] 12 0.0000
13 Insulin [EPC] 1 0.0000
14 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
15 Azole Antifungal [EPC] 3 0.0000
16 Alkylating Drug [EPC] 4 0.0000
17 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
18 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
19 Corticosteroid [EPC] 16 0.0000
20 Vitamin C [EPC] 5 0.0000
21 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
22 Tumor Necrosis Factor Blocker [EPC] 10 0.0000
23 GLP-1 Receptor Agonist [EPC] 4 0.0000
24 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
25 Benzodiazepine [EPC] 5 0.0000
26 Platelet Aggregation Inhibitor [EPC] 4 0.0000
27 Proton Pump Inhibitor [EPC] 4 0.0000
28 Loop Diuretic [EPC] 3 0.0000
29 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
30 Janus Kinase Inhibitor [EPC] 1 0.0000
31 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
33 Thiazide Diuretic [EPC] 1 0.0000
34 Atypical Antipsychotic [EPC] 2 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
36 Platinum-based Drug [EPC] 1 0.0000
37 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
38 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
39 Thalidomide Analog [EPC] 1 0.0000